NANJING, China
Coming into 2014, Biotech China has gathered more than 300 exhibitors and received about 1,500 online visitor registrations from 12 countries and regions. Especially for the popular overseas pavilions, they have attracted companies from more than 12 nations, including 4 national pavilions from Israel, the United Kingdom, Switzerland and Korea, 6 exhibitors from the USA, 16 exhibitors from Taiwan China, as well as other overseas exhibitors from Denmark, Germany, France, Japan, India, Singapore, Canada, among others.
Exhibitors include a wide range of companies, such as Sinopeg Biotech, novoprotein, Genloci Biotechnologies, GenScript, Canaan Pharmaceutical Equipment, MD Biosciences, Valin Technologies, Bio-Chem Engineering, Meissner Filtraton, Life Sciences Advanced Technologies, Stoel Rives, Springer, etc.
Chinese exhibitors are mainly from bio medicine industrial bases among which Nanjing Biopharmaceutical Valley (NJBV) is being highlighted. The State-level Biomedical Science and Technology Incubator is on the leading place in terms of booth space and exhibitor rankings, indicating itself as a dynamic biopharmaceutical industrial base. More than 30 firms and research institutes will present a live showcase of cutting-edge technology and sophisticated equipments by bio pharmaceutical industry in Nanjing.
Overseas companies will meet Nanjing Biopharmaceutical Valley on site, besides attending the fair, you will get a great chance for investment in Nanjing.
NJBV is located in the State-level Nanjing High-Tech Zone, the northwest of the city, adjacent to the north shore of Yangtze River. Nanjing Biopharmaceutical Valley aims to become the biopharmaceutical industrial base and high-end biopharmaceutical research area according to the industrial layout set by Nanjing City Committee of the CPC and the municipal Government. Currently, there are around 150 bio-pharmaceutical enterprises in NJBV, covering the fields of chemical medicine, bio-medicine, diagnostic reagents, medical instruments, Chinese traditional medicine, and R&D outsourcing service, and etc. In 2012, the business income of biopharmaceutical industry achieved around RMB 9.4 billion.
As a Biopharmaceutical Park, NJBV enjoys the greatest investment potential, especially with distinct advantage at research achievement transfer. State-level Biomedical Science and Technology Incubator is located in the built-up area of Nanjing Biopharmaceutical Valley covering an area of 65,000 m2. Currently, there are 21 leading biopharmaceutical enterprises and high-tech players in this area.
Nanjing Biopharmaceutical Valley Public Service Platform is designed to meet enterprises demand, integrating resources in order to provide various services on instruments, information, technology, and investment. It strives to promote innovation capacities, enlarge the scope of the industry, enhance competitiveness, and achieve the sustainable development of the biopharmaceutical industry. The platform will offer public services including Biopharmaceutical public instrument analysis Service, Biopharmaceutical Public Information Service, Organic Synthesis R&D Service, Pilot Scale Experiment Service, Investment and Finance Service and Business Service.
More information about Nanjing City:
- Scientific and Human Resource Advantages
Nanjing is one of the four R&D and education centers in China, especially for its top-ranking comprehensive biomedical R&D strength.
- 16 of the universities have Biopharmaceutical related majors, with nearly 20,000 on-campus students
Nanjing University, Southeast University, Nanjing University of Technology, China Pharmaceutical University, Nanjing Medical University, Nanjing University of Chinese Medicine, Nanjing Normal University, among others.
- 67 Biomedical research institutes
Nanjing owns 6 national level research institutes, 57 provincial level research institutes, and 4 municipal research institutes, such as National biochemistry engineering research center, National Resource Center for Mutant Mice and Jiangsu province Drug research institute
- 18 Authorities in the field of Biopharmaceutical
6 Academicians of China Academy of Science, 10 Academicians of China Academy of Engineering, and 2 Masters of Traditional Chinese Medical Science
- Location Advantage
As a city in eastern China, it’s adjacent to six provinces and one municipality, which altogether account for one half of China’s economy scale.
In addition, it’s located in Yangtze River delta and surrounded by Jiangsu Province, which enjoys advantages at biopharmaceutical R&D.
CONTACT
for 2014 Biotech China
Mr. Yunpeng Gong (Eric), +86-25-83518305
gongyp@biotechchina-nj.com
